Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes.
KCNQ2
Kv7.2 subunits
PIP2
alternative splicing
calmodulin
epileptic encephalopathy
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2022
2022
Historique:
received:
09
02
2022
accepted:
10
05
2022
entrez:
30
6
2022
pubmed:
1
7
2022
medline:
1
7
2022
Statut:
epublish
Résumé
Pathogenic variants in KCNQ2 encoding for Kv7.2 potassium channel subunits have been found in patients affected by widely diverging epileptic phenotypes, ranging from Self-Limiting Familial Neonatal Epilepsy (SLFNE) to severe Developmental and Epileptic Encephalopathy (DEE). Thus, understanding the pathogenic molecular mechanisms of KCNQ2 variants and their correlation with clinical phenotypes has a relevant impact on the clinical management of these patients. In the present study, the genetic, biochemical, and functional effects prompted by two variants, each found in a non-familial SLNE or a DEE patient but both affecting nucleotides at the KCNQ2 intron 6-exon 7 boundary, have been investigated to test whether and how they affected the splicing process and to clarify whether such mechanism might play a pathogenetic role in these patients. Analysis of KCNQ2 mRNA splicing in patient-derived lymphoblasts revealed that the SLNE-causing intronic variant (c.928-1G > C) impeded the use of the natural splice site, but lead to a 10-aa Kv7.2 in frame deletion (Kv7.2 p.G310Δ10); by contrast, the DEE-causing exonic variant (c.928G > A) only had subtle effects on the splicing process at this site, thus leading to the synthesis of a full-length subunit carrying the G310S missense variant (Kv7.2 p.G310S). Patch-clamp recordings in transiently-transfected CHO cells and primary neurons revealed that both variants fully impeded Kv7.2 channel function, and exerted strong dominant-negative effects when co-expressed with Kv7.2 and/or Kv7.3 subunits. Notably, Kv7.2 p.G310S, but not Kv7.2 p.G310Δ10, currents were recovered upon overexpression of the PIP
Identifiants
pubmed: 35770094
doi: 10.3389/fphar.2022.872645
pii: 872645
pmc: PMC9234691
doi:
Types de publication
Journal Article
Langues
eng
Pagination
872645Informations de copyright
Copyright © 2022 Mosca, Rivolta, Labalme, Ambrosino, Castellotti, Gellera, Granata, Freri, Binda, Lesca, DiFrancesco, Soldovieri and Taglialatela.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Biol Chem. 2006 Jan 6;281(1):418-28
pubmed: 16260777
Br J Pharmacol. 2000 Feb;129(3):413-5
pubmed: 10711337
Physiology (Bethesda). 2011 Oct;26(5):365-76
pubmed: 22013194
J Gen Physiol. 2010 Feb;135(2):99-114
pubmed: 20100891
Cell. 1991 Jun 14;65(6):949-59
pubmed: 2044154
Pflugers Arch. 2013 Jul;465(7):945-53
pubmed: 23291709
Pharmacol Res. 2020 Oct;160:105200
pubmed: 32942014
J Biol Chem. 2000 May 5;275(18):13343-8
pubmed: 10788442
Ann Neurol. 2012 Jan;71(1):15-25
pubmed: 22275249
Epilepsia. 2017 Jan;58(1):e10-e15
pubmed: 27861786
Sci Rep. 2016 Dec 01;6:38167
pubmed: 27905566
J Gen Physiol. 2003 Jul;122(1):17-31
pubmed: 12810850
J Neurosci. 2015 Mar 4;35(9):3782-93
pubmed: 25740509
Biochim Biophys Acta. 2015 Sep;1852(9):1856-66
pubmed: 26073431
Neuron. 2001 Oct 11;32(1):79-88
pubmed: 11604140
Biophys J. 2012 Mar 21;102(6):1372-82
pubmed: 22455920
Mol Neurobiol. 2018 Aug;55(8):7009-7024
pubmed: 29383681
Nat Rev Neurosci. 2007 Dec;8(12):921-34
pubmed: 17971783
Ann Neurol. 2014 Mar;75(3):382-94
pubmed: 24318194
Neurol Genet. 2016 Aug 22;2(5):e96
pubmed: 27602407
Annu Rev Physiol. 1997;59:483-504
pubmed: 9074774
Int J Nanomedicine. 2018 Jul 11;13:4059-4071
pubmed: 30034232
J Physiol. 2008 Apr 1;586(7):1811-21
pubmed: 18238808
J Neurosci. 2005 Oct 26;25(43):9825-35
pubmed: 16251430
J Physiol. 2000 Feb 1;522 Pt 3:349-55
pubmed: 10713961
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20093-8
pubmed: 24277843
J Neurosci. 2005 Mar 30;25(13):3400-13
pubmed: 15800195
Science. 1998 Dec 4;282(5395):1890-3
pubmed: 9836639
Neuron. 2003 Mar 27;37(6):963-75
pubmed: 12670425
Neurology. 2013 Nov 5;81(19):1697-703
pubmed: 24107868
EMBO J. 2012 May 29;31(14):3147-56
pubmed: 22643219
Hum Mutat. 2014 Mar;35(3):356-67
pubmed: 24375629
J Biol Chem. 2002 Aug 9;277(32):28545-53
pubmed: 12032157
Mol Pharmacol. 2018 Oct;94(4):1155-1163
pubmed: 30021858
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4386-91
pubmed: 23440208